Markets
Stocks
Mutual Funds & ETF's
Sectors
Tools
Overview
Market News
Currencies
International
Search InvestCenter
Recent Quotes
My Watchlist
Top Indices
My Portfolio

AbbVie (NY:ABBV)

213.66 -4.38 (-2.01%)
Streaming Delayed Price Updated: 11:41 AM EST, Nov 3, 2025 Add to My Watchlist
Quote
Overview Detailed Quote Charting Historical Prices
News
All News News Headlines Press Releases
Research
Quarterly Reports Insider Filings Other Filings

Price and Volume

Detailed Quote
Volume 2,086,478
Open 216.68
Bid (Size) 213.60 (100)
Ask (Size) 213.71 (200)
Prev. Close 218.04
Today's Range 213.37 - 219.00
52wk Range 163.81 - 244.81
Shares Outstanding N/A
Dividend Yield 3.07%
Chart for (: )
Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

Top News

More News
My Favorite Dividend King to Buy in November
This member of dividend royalty checks off lots of boxes for investors. 
Via The Motley Fool
Topics Intellectual Property
2 Magnificent Dividend Stocks to Buy and Hold Forever
Some might call them boring businesses, but they have tremendous dividend growth track records. 
Via The Motley Fool
Topics Economy Intellectual Property

Performance

YTD
+19.1%
+19.1%
1 Month
-8.7%
-8.7%
3 Month
+8.3%
+8.3%
6 Month
+9.0%
+9.0%
1 Year
+6.6%
+6.6%

More News

Read More
2 Top ETFs I Can't Wait to Buy More of in My Retirement Account This November
Via The Motley Fool
Topics ETFs Retirement Stocks
ABBV Stock: $250 May Be the New Floor After Big Q3 Earnings Beat
Via MarketBeat
Why AbbVie Stock Flopped on Friday
Via The Motley Fool
Looking Into AbbVie Inc's Recent Short Interest
Via Benzinga
AbbVie's Earnings Outlook
Via Benzinga
Amgen Solidifies Biotech Dividend Prowess with $2.38 Q4 2025 Payout
Via MarketMinute
Topics Intellectual Property
Exploring the top movers within the S&P500 index during today's session.
Via Chartmill
AI Revolutionizes Pharma: Smarter Excipients for Safer, More Potent Drugs
Via TokenRing AI
Topics Artificial Intelligence Supply Chain
Discover which S&P500 stocks are making waves on Friday.
Via Chartmill
AI: The Pharmaceutical Sector’s New Catalyst for a Healthier Future
Via TokenRing AI
Topics Animal Testing Artificial Intelligence Economy
Why AbbVie (ABBV) Shares Are Falling Today
Via StockStory
Topics World Trade
Nasdaq 100 Rebounds, Amazon Jumps 10% On Strong Earnings: What's Moving Markets Friday?
Via Benzinga
AbbVie Raises 2025 Outlook Helped By Strong Immunology Growth, Boost Dividend
Via Benzinga
Gapping S&P500 stocks in Friday's session
Via Chartmill
AbbVie Q3 2025 Earnings Call Transcript
Via The Motley Fool
Topics Earnings Economy
ABBVIE INC (NYSE:ABBV) Reports Mixed Q3 2025 Results with EPS Beat and Revenue Miss
Via Chartmill
AbbVie Beats Third-Quarter Forecasts As Immunology Kingpin Grows 47%
Via Investor's Business Daily
AbbVie’s (NYSE:ABBV) Q3 Sales Beat Estimates
Via StockStory
Topics Earnings
Eli Lilly Extends Lead In $150B Obesity Drug Race As Novo, Pfizer Clash — Here's How ETFs Stand To Gain
Via Benzinga
Topics ETFs
Railway Pension Liquidates All 1.65M CCJ Shares Worth $122.8 Million
Via The Motley Fool
Topics Supply Chain
AbbVie (ABBV) Reports Earnings Tomorrow: What To Expect
Via StockStory
Topics Artificial Intelligence
Want Decades of Passive Income? Buy This Index Fund and Hold It Forever.
Via The Motley Fool
Topics ETFs Regulatory Compliance Stocks
Billionaire Israel "Izzy" Englander Has Loaded Up on This Dividend King. Should You?
Via The Motley Fool
Topics Intellectual Property

Frequently Asked Questions

Is AbbVie publicly traded?
Yes, AbbVie is publicly traded.
What exchange does AbbVie trade on?
AbbVie trades on the New York Stock Exchange
What is the ticker symbol for AbbVie?
The ticker symbol for AbbVie is ABBV on the New York Stock Exchange
What is the current price of AbbVie?
The current price of AbbVie is 213.66
When was AbbVie last traded?
The last trade of AbbVie was at 11/03/25 11:41 AM ET
Stock Quote API & Stock News API supplied by www.cloudquote.io
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the Privacy Policy and Terms Of Service.
© 2025 FinancialContent. All rights reserved.